ArticleESMO real world data and digital oncology2026
Exploring social determinants of health and immunotherapy utilization in patients with stage III non-small-cell lung cancer after definitive chemoradiation.
C Hwang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.